vesicular stomatitis virus-based ebola vaccine is well-tolerated and protects immunocompromised nonhuman primates水泡性口炎virus-based埃博拉病毒疫苗免疫系统很好,保护受损非人灵长类动物.pdfVIP

下载本文档

0
0
约7.32万字
约 9页
2017-09-12 发布于上海
举报
版权申诉

vesicular stomatitis virus-based ebola vaccine is well-tolerated and protects immunocompromised nonhuman primates水泡性口炎virus-based埃博拉病毒疫苗免疫系统很好,保护受损非人灵长类动物.pdf

1、原创力文档（book118）网站文档一经付费（服务费），不意味着购买了该文档的版权，仅供个人/单位学习、研究之用，不得用于商业用途，未经授权，严禁复制、发行、汇编、翻译或者网络传播等，侵权必究。。
2、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己接受本站规则且自行承担风险，本站不退款、不进行额外附加服务；查看《如何避免下载的几个坑》。如果您已付费下载过本站文档，您可以点击这里二次下载。
3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等，请点击“版权申诉”（推荐），也可以打举报电话：400-050-0827(电话支持时间：9:00-18:30)。
4、该文档为VIP文档，如果想要下载，成为VIP会员后，下载免费。
5、成为VIP后，下载本文档将扣除1次下载权益。下载后，不支持退款、换文档。如有疑问请联系我们。
6、成为VIP后，您将拥有八大权益，权益包括：VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
7、VIP文档为合作方或网友上传，每下载1次，网站将根据用户上传文档的质量评分、类型等，对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档

vesicular stomatitis virus-based ebola vaccine is well-tolerated and protects immunocompromised nonhuman primates水泡性口炎virus-based埃博拉病毒疫苗免疫系统很好,保护受损非人灵长类动物

Vesicular Stomatitis Virus-Based Ebola Vaccine Is Well- Tolerated and Protects Immunocompromised Nonhuman Primates 1,2,3,4,5,6 1,4,6 7 1,6 Thomas W. Geisbert *, Kathleen M. Daddario-DiCaprio , Mark G. Lewis , Joan B. Geisbert , 7 8 9 7 10 8,11,12 Allen Grolla , Anders Leung , Jason Paragas , Lennox Matthias , Mark A. Smith , Steven M. Jones , Lisa E. Hensley6, Heinz Feldmann8,12¤, Peter B. Jahrling5,9 1 National Emerging Infectious Diseases Laboratories Institute, Boston, Massachusetts, United States of America, 2 Department of Microbiology, Boston University School of Medicine, Boston, Massachusetts, United States of America, 3 Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, United States of America, 4 Department of Pathology, Uniformed Services University of the Health Sciences, Bethesda, Maryland, United States of America, 5 Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America, 6 Virology Division, BIOQUAL, Rockville, Maryland, United States of America, 7 BIOQUAL, Rockville, Maryland, United States of America, 8 Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada, 9 Emerging Viral Pathogens Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America, 10 Pathology Division, U